Uric acid metabolism in patients with primary gout and the metabolic syndrome

Nucleosides, Nucleotides and Nucleic Acids

Volumn 29, Issue 4-6, 2010, Pages 330-334

  Fraile, J M ^a   Puig, J G ^a   Torres, Rosa J ^a   De Miguel, Eugenio ^a   Martínez, Pedro ^a   Vazquez J J ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Gout; hyperuricemia; MS; uric acid

Indexed keywords

CREATININE; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; FEMALE; GOUT; HUMAN; HYPERURICEMIA; MALE; METABOLIC SYNDROME X; METABOLISM; OUTCOME ASSESSMENT; PILOT STUDY; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINARY EXCRETION;

FEMALE; GOUT; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; URIC ACID;

EID: 77953712103     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257771003741273     Document Type: Article

References (13)

1. Puig, J.G.; Martínez, M.A.; Mora, M.; Fraile, J.M.; Montoya, F.; Torres, R.J. Serum urate, MS and cardiovascular risk factors: a population-based study. Nucleosides Nucleotides Nucleic Acids 2007, 27, 620-623.
2. Quiñones Galvan, A.; Natali, A.; Baldi, S.; Frascerra, S.; Sanna, G.; Ciociaro, D.; Ferrannini, E. Effect of insulin on uric acid excretion in humans Am. J. Physiol. 1995, 268, E1-E5.
3. Nakagawa, T.; Tuttle, K.R.; Short, R.A.; Johnson, R.J. Fructose-induced hyperuricemia as a casual mechanism for the epidemic of the MS. Nat. Clin. Pract. Nephrol. 2005, 1, 80-86.
4. Nakagawa, T.; Hu, H.; Zharikov, S.; Tuttle, K.R.; Short, R.A.; Glushakova, O.; Ouyang, X.; Feig, D.I.; Block, E.R.;Herrera-Acosta, J.; Patel, J.M.; Johnson, R.J. A causal role for uric acid in fructose induced MS. Am. J. Physiol. Renal. Physiol. 2006, 290, F625-31.6.
5. Puig, J.G.; Ruilope, L.M. Uric acid as a cardiovascular risk factor in arterial hypertension. J. Hypertens. 1999, 17, 869-872.
6. Lopez-Suarez, A.; Elvira-Gonźalez, J.; Bascuñana-Quirell, A.; Rosal-Obrador, J.; Mich́an-Doña, A.; Escribano-Serrano, J.; Benítez-Rodríguez, E. Grupo para el Estudio del Riesgo Vascular Alcaĺa (GERVA). Serum urate levels and urinary uric acid excretion in subjects with MS. Med. Clin. (Barc.) 2006, 126, 321-324.
7. Hjortnaes, J.; Algra, A.; Olijhoek, J.; Huisman, M.; Jacobs, J.; van der Graaf, Y.; Visseren, F. Serum uric acid levels and risk for vascular diseases in patients with MS. J. Rheumatol. 2007, 34, 1882-1887.
8. Ozsahin, A.K.;Gokcel, A.; Sezgin, N.; Akbaba, M.; Guvener, N.;Ozisik, L.; Karademir, B.M. Prevalence of the MS in a Turkish adult population. Diabetes Nutr. Metab. 2004, 17, 230-234.
9. Ford, E.S.; Cook, S.; Choi, H.K. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007, 115, 2526-2532.
10. Wallace, S.L. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977, 20, 895-900.
11. Grundy, S.M.; Brewer, H.B., Jr.; Cleeman, J.I.; Smith, S.C., Jr.; Lenfant, C. American Heart Association; National Heart, Lung, and Blood Institute. Definition of MS: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109, 433-438.
12. Strazzullo, P.; Barbato, A.; Galletti, F.; Barba, G.; Siani, A.; Iacone, R.; D'Elia, L.; Russo, O.; Versiero, M.; Farinaro, E.; Cappuccio, F.P. Abnormalities of renal sodium handling in the MS: results of the Olivetti Heart Study. J. Hypertens. 2006, 24, 1633-1639.
13. Strazzullo, P.; Puig, J.G. Uric acid and oxidative stress: relative impact on cardiovascular risk. Nutr. Metab. Cardiovasc. Dis. 2007, 17, 409-414.